CDC committee supports expanded criteria for PCV13 vaccine

02/27/2013 | AAFP News Now

The CDC's Advisory Committee on Immunization Practices voted to expand age recommendations for certain individuals for the 13-valent pneumococcal conjugate vaccine and to include the Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus toxoid vaccine for high-risk children in the Vaccines for Children program. The committee approved four new influenza vaccine formulations for the 2013-14 flu season, along with recommendations for timing and spacing of vaccinations.

View Full Article in:

AAFP News Now

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ